News - Main

Dennis Onyeka Frank-Ito, PhD, has been appointed Associate Professor with Tenure in the Department of Head and Neck Surgery & Communication Sciences, effective October 1, 2025.

Cancer survivors are more likely than the general population to use medications for depression and anxiety, but access to these treatments varies widely by demographics, insurance status, and cancer type, according to a new study.

Dr. Debara Tucci has been appointed Professor Emeritus at Duke, honoring her impactful career in otolaryngology, leadership in faculty development, and continued contributions through mentorship and national research leadership.

Dr. Nosa Osazuwa-Peters' latest publication in JAMA Network Open reveals racial disparities in antidepressant and anxiolytic use among U.S. cancer survivors, despite overall higher usage in this group.

A recent study led by Steven Eliades MD, PhD, A

Duke Health offers TEP surgery for throat cancer patients post-laryngectomy, enabling natural-sounding speech. “It’s a game-changer,” says Dr. Trinitia Cannon, head and neck surgeon at Duke Cancer Center Raleigh.

Duke Cancer Institute launches the Thyroid Cancer Center, led by Drs. Scheri, Frieze, Kahmke, and Muzaffar. Dr. Kahmke and team offer expert, collaborative care across specialties for thyroid cancer patients.

Duke’s Blake Wilson has been a pioneer in developing the modern cochlear implant, working on the technology with colleagues at RTI International in Research Triangle Park and co-founding the Cochlear Implant Program at Duke in 1984.

Dr. Danai Fannin, PhD, CCC-SLP, adjunct faculty in Duke HNS&CS, has been named a 2025 ASHA AFellow recipient for her exceptional contributions to communication sciences, reflecting Duke’s continued leadership in advancing clinical excellence.

We are excited to announce that we will be hosting a Virtual Town Hall. This session will start with an introduction from our faculty and residents, followed by an exclusive opportunity to chat with residents alone.